.png){kind=icon}
.png){kind=icon}
Return
NUTRISCORE: A Novel Nutrition-Based Nomogram to Predict Severe Neutropenia After Adjuvant Chemotherapy in Gastric Cancer
.png){kind=icon}
PRE
AI
C
L
Y
S
DOI：10.1177/15347354261447851.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
<jats:sec>
<jats:title>Background:</jats:title>
<jats:p>To develop and validate a clinically applicable nomogram (NUTRISCORE) predicting severe neutropenia (Grade 3/4) across cycles 2 to 8 of adjuvant chemotherapy in gastric cancer.</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Methods:</jats:title>
<jats:p>This retrospective cohort study analyzed 391 patients receiving postoperative adjuvant chemotherapy (CAPEOX/XELOX/SOX) following curative laparoscopic D2 gastrectomy. Cohorts were stratified into derivation (n = 318; 1518 cycles) and validation (n = 73; 356 cycles) sets. Generalized Estimating Equations (GEE) were used to account for within-patient correlation of multiple cycles. Multivariable logistic regression identified independent predictors, with subsequent nomogram construction using R. Model performance was quantified through AUC-ROC and decision curve analysis (DCA).</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Results:</jats:title>
<jats:p>
Four predictors emerged: age > 60 years (OR = 2.1,
<jats:italic toggle="yes">P</jats:italic>
< .01), prealbumin ≤ 180 mg/L (OR = 3.4,
<jats:italic toggle="yes">P</jats:italic>
= .002), PNI < 45 (OR = 2.8,
<jats:italic toggle="yes">P</jats:italic>
= .008), and prior cycle neutropenia (OR =4.7,
<jats:italic toggle="yes">P</jats:italic>
< .001). The nomogram achieved AUCs of 0.825 (95% CI 0.789-0.860) and 0.810 (0.783-0.835) in derivation and validation cohorts, with DCA confirming clinical utility across threshold probabilities (4%-65% in derivation, 3%-63% in validation), supporting its use for guiding G-CSF prophylaxis at clinically relevant risk thresholds (>15%).
</jats:p>
</jats:sec>
<jats:sec>
<jats:title>Conclusions:</jats:title>
<jats:p>We establish a nutrition-centric predictive tool for severe neutropenia, demonstrating robust accuracy in stratifying chemotherapy toxicity risk. This model directly informs personalized prophylactic strategies, warranting prospective multicenter validation.</jats:p>
</jats:sec>
Journal
IF:
2.8
Papers:
171
Citations:
3.5K
Organization
Cited Papers